Special Issue "Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights 2.0"
Deadline for manuscript submissions: 31 December 2021.
Interests: NAFLD; diabetes; ceramics; gender disparity in science
Special Issues and Collections in MDPI journals
Nonalcoholic fatty liver disease (NAFLD) is an important health care problem worldwide. It affects 30% of adults in the general population, 70% of patients with type 2 diabetes (T2DM), and all patients with obesity. Importantly, NAFLD is now the second most frequent indication for liver transplantation in the United States. In the last several decades, it has become evident that NAFLD is not only associated with serious liver-related complications, but also with relevant metabolic, cardiovascular, and renal complications. Although the pathogenesis of NAFLD is complex, it was established that NAFLD is strongly linked to insulin resistance, abdominal obesity, and T2DM. Based on this evidence, in 2020, some authors have proposed the change of the terminology from NAFLD to metabolic associated fatty liver disease (MAFLD), as well as an update of the definition of this fatty liver disease. Regardless of terminology used, however, it is clearly evident that NAFLD/MAFLD is a dynamic disease, characterized by many factors that change over time. In this regard, specific phenotypes of NAFLD/MAFLD may be broadly driven by environmental factors, genetic predisposition, or metabolic factors.
This Special Issue of the International Journal of Molecular Sciences will focus on recent developments in the area of NAFLD/MAFLD pathogenesis and treatment, as well as new insights into the mechanisms and therapies for NAFLD/MAFLD. It will cover a selection of recent research topics and current review articles in the field of NAFLD/MAFLD. Experimental papers, up-to-date review articles, and commentaries are all welcome.
Dr. Alessandro Mantovani
Dr. Andrea Dalbeni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nonalcoholic fatty liver disease (NAFLD)
- metabolic associated fatty liver disease (MAFLD)
- nonalcoholic steatohepatitis (NASH)
- fatty liver
- cardiovascular disease